EVH Stock - Evolent Health, Inc.
Unlock GoAI Insights for EVH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.55B | $1.96B | $1.35B | $907.96M | $924.64M |
| Gross Profit | $367.35M | $460.47M | $316.58M | $250.41M | $228.06M |
| Gross Margin | 14.4% | 23.4% | 23.4% | 27.6% | 24.7% |
| Operating Income | $-40,485,000 | $-71,211,000 | $3.64M | $-42,411,000 | $-262,847,000 |
| Net Income | $-61,623,000 | $-113,040,000 | $-19,164,000 | $-37,601,000 | $-334,246,000 |
| Net Margin | -2.4% | -5.8% | -1.4% | -4.1% | -36.1% |
| EPS | $-0.81 | $-1.28 | $-0.20 | $-0.36 | $-3.94 |
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Visit WebsiteEarnings History & Surprises
EVHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.10 | $0.05 | -50.0% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $0.09 | $-0.10 | -211.1% | ✗ MISS |
Q2 2025 | May 8, 2025 | $0.09 | $0.06 | -33.3% | ✗ MISS |
Q1 2025 | Feb 20, 2025 | $0.38 | $-0.02 | -105.3% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.30 | $0.04 | -86.7% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.21 | $0.30 | +42.9% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.21 | $0.34 | +61.9% | ✓ BEAT |
Q1 2024 | Feb 22, 2024 | $0.11 | $0.23 | +109.1% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.09 | $0.30 | +233.3% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $0.09 | $0.14 | +55.6% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.15 | $0.21 | +40.0% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $0.06 | $0.10 | +66.7% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $0.08 | $0.59 | +637.5% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $0.05 | $0.10 | +105.9% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $0.00 | $0.12 | +6085.6% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.01 | $0.08 | +860.4% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $-0.03 | $-0.03 | -8.7% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $-0.06 | $-0.02 | +66.7% | ✓ BEAT |
Latest News
Frequently Asked Questions about EVH
What is EVH's current stock price?
What is the analyst price target for EVH?
What sector is Evolent Health, Inc. in?
What is EVH's market cap?
Does EVH pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to EVH for comparison